Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

251
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
251
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

212
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
212
Brain Imaging01:14

Brain Imaging

629
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
629
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

460
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
460
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

758
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
758

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Impact of Postlabeling Delay on Arterial Spin-Labeling MRI-Based Measures of Cerebral Blood Flow in a Simultaneous PET/MRI Study of Aging.

AJNR. American journal of neuroradiology·2026
Same author

Digital maze test reveals cognitive performance patterns associated with amyloid-β and tau.

Neuropsychology·2026
Same author

Why it should be "Alzheimer disease" rather than "Alzheimer's disease".

Free neuropathology·2026
Same author

Amyloid spatial extent with florbetapir-PET for early detection of preclinical Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2026
Same author

Human Cerebral Cortex Organization Characterized by Functional PET-FDG "Metabolic Connectivity".

bioRxiv : the preprint server for biology·2026
Same author

A Cross-modality Transformer Network for MR-guided Low-dose Tau PET Image Denoising.

IEEE transactions on radiation and plasma medical sciences·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

751

Consorcio de Imagenología de Alzheimer

Charles D Chen1, Cinthya Aguero2, Alexandra N Melloni2

  • 1Massachusetts General Hospital, Charlestown, MA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
Resumen
Este resumen es generado por máquina.

Los biomarcadores de tomografía por emisión de positrones (PET) para amiloide-β y tau predicen la patología cerebral, pero la PET de tau requiere ajustes para valores atípicos para reflejar con precisión la distribución de los ovillos neurofibrilares de tau. Las métricas individualizadas de PET de tau mejoran la predicción de las evaluaciones neuropatológicas.

Palabras clave:
PET amiloidePET tauAlzheimerneuropatologíabiomarcadores de imagen

Más Videos Relacionados

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

751
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

11.0K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.8K

Área de la Ciencia:

  • Neuroimagen
  • Neuropatología
  • Investigación de la Enfermedad de Alzheimer

Sus antecedentes:

  • El Harvard Aging Brain Study (HABS) investiga las diferencias entre el envejecimiento normal y la enfermedad de Alzheimer (EA) preclínica.
  • Dieciséis participantes del HABS donaron sus cerebros para evaluación neuropatológica.
  • Este estudio evalúa el poder predictivo de los biomarcadores de PET antemortem para los hallazgos neuropatológicos postmortem.

Objetivo del estudio:

  • Comparar biomarcadores de PET antemortem (amiloide-β y tau) con evaluaciones neuropatológicas postmortem.
  • Determinar la correlación entre las métricas de imagen de PET y la carga/distribución de placas amiloides y ovillos de tau.
  • Identificar los factores que contribuyen a las discrepancias entre los hallazgos de PET y la neuropatología.

Principales métodos:

  • Evaluación neuropatológica de placas amiloides (fase Thal/puntuación A), ovillos de tau (etapa Braak NFT/puntuación B) y placas neuríticas (puntuación CERAD NP/puntuación C).
  • Las métricas de PET de amiloide-β (PiB) incluyeron la relación de volumen de distribución (DVR) y la extensión espacial (EXT) de la corteza frontal, temporal lateral, parietal y retrosplenial (FLR).
  • Las métricas de PET de tau (flortaucipir, FTP) incluyeron las relaciones de valor de captación estandarizado (SUVR) del lóbulo temporal medial (MTL), la neocorteza temporal (NEO-T) y el temporal total, analizadas bilateral y lateralmente.

Principales resultados:

  • La relación entre el volumen de distribución (DVR) y la extensión espacial (EXT) de la PET de PiB de amiloide-β se correlacionó significativamente con las puntuaciones de placa amiloide (A) y CERAD (C).
  • Las relaciones de valor de captación estandarizado (SUVR) iniciales de la PET de tau (FTP) no se correlacionaron significativamente con la etapa de Braak (B).
  • Después de eliminar los valores atípicos, los SUVR de la neocorteza temporal (NEO-T) y temporal total se correlacionaron significativamente con la puntuación B; los SUVR lateralizados fortalecieron aún más estas correlaciones.

Conclusiones:

  • Las métricas de PET de amiloide-β se alinean bien con la distribución y densidad de las placas amiloides.
  • Las métricas de PET de tau se correlacionan con la distribución de los ovillos de tau solo después de tener en cuenta los valores atípicos, lo que sugiere que las discrepancias PET-neuropatológicas son más comunes con tau.
  • Las métricas individualizadas de PET de tau que tienen en cuenta la heterogeneidad de la tauopatía son cruciales para la predicción precisa de las evaluaciones neuropatológicas.